Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
Marked urinary loss of lipoprotein lipase activator in experimental rat nephrotic syndrome may be partly responsible for its deficiency in plasma very low density lipoproteins.
D000818:Animals; D001053:Apolipoproteins / Q000172:deficiency* / Q000378:metabolism / Q000494:pharmacology; D004789:Enzyme Activation; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D009404:Nephrotic Syndrome / Q000378:metabolism*; D010455:Peptides / Q000172:deficiency / Q000378:metabolism / Q000494:pharmacology; D051381:Rats
D001053:Apolipoproteins; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D010455:Peptides; D008071:Lipoprotein Lipase